Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Year-over-year operating cash flow growth rate
Percentile
P9
Near historical low
vs 5Y Ago
-7.4x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -147.40% |
| Q3 2025 | 196.43% |
| Q2 2025 | 20.77% |
| Q1 2025 | 21.08% |
| Q4 2024 | -87.71% |
| Q3 2024 | 47.68% |
| Q2 2024 | 17.99% |
| Q1 2024 | -37.50% |
| Q4 2023 | 2.05% |
| Q3 2023 | -217.22% |
| Q2 2023 | -1.72% |
| Q1 2023 | 7.35% |
| Q4 2022 | -371.45% |
| Q3 2022 | 125.41% |
| Q2 2022 | 13.90% |
| Q1 2022 | 4.12% |
| Q4 2021 | 17.93% |
| Q3 2021 | -524.09% |
| Q2 2021 | 123.17% |
| Q1 2021 | -76.83% |
| Q4 2020 | 19.83% |
| Q3 2020 | 11.47% |
| Q2 2020 | -8.70% |
| Q1 2020 | 3.74% |
| Q4 2019 | -13.63% |
| Q3 2019 | -43.13% |
| Q2 2019 | 26.99% |
| Q1 2019 | -0.20% |
| Q4 2018 | -34.38% |
| Q3 2018 | -39.59% |
| Q2 2018 | -70.84% |
| Q1 2018 | -16.62% |
| Q4 2017 | -71.81% |
| Q3 2017 | 6.68% |
| Q2 2017 | -126.33% |
| Q1 2017 | 0.00% |